Ushbu ish iqtibos qilgan ishlar

23 ta ish

Ish: THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER

1. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

   Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard +7

   Maqola20075 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.198076

2. Triple-Negative Breast Cancer: Molecular Subtypes and New Targets for Therapy

   Brian D. Lehmann, Jennifer A. Pietenpol, Antoinette R. Tan

   Maqola20154 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434428

3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

   Patricia Cortazar, Lijun Zhang, Michael Untch +34

   Sharh maqola20144 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434433

4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

   Brian D. Lehmann, Joshua A. Bauer, Xi Chen +4

   Maqola20114 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434438

5. Gene expression profiling predicts clinical outcome of breast cancer

   Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver +13

   Maqola20023 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.290827

6. Globocan 2000 : cancer incidence, mortality and prevalence worldwide

   Jacques Ferlay, Paola Pisani, Donald Maxwell Parkin

   Kitob20013 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434426

7. Molecular Subtype of Breast Cancer Metastases Significantly Influences Patient Post-Relapse Survival

   Nicholas P. Tobin, J. Chuck Harrell, Søren Brage +5

   Maqola20143 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434429

8. Pathological complete response in breast cancer – Authors' reply

   Patricia Cortazar, Charles E. Geyer, Luca Gianni +2

   Boshqa20153 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434430

9. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

   Gϋnter von Minckwitz, Michael Untch, Eveline Nüesch +20

   Maqola20103 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.434431

10. Characteristics of triple-negative breast cancer

    Tim C. de Ruijter, Jürgen Veeck, Joep P.J. de Hoon +2

    Sharh maqola20103 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434432

11. Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

    Valentina Guarneri, Kristine Broglio, Shu‐Wan Kau +8

    Maqola20063 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434434

12. Triple-Negative Breast Cancer: An Unmet Medical Need

    Clifford A. Hudis, Luca Gianni

    Sharh maqola20113 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434436

13. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

    Thérese Sørlie, Charles M. Perou, Robert Tibshirani +14

    Maqola20013 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434437

14. Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

    Mark Ayers, W. Fraser Symmans, James Stec +15

    Maqola20043 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434439

15. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

    Roman Rouzier, Charles M. Perou, W. Fraser Symmans +13

    Maqola20053 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434441

16. Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

    Gabriel N. Hortobágyi

    Maqola20123 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434442

17. Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options

    Bernardo L. Rapoport, Simon Nayler, Georgia Demetriou +2

    Maqola20143 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434443

18. Survival in triple-negative breast cancer (TNBC): Evidence from the SEER database 2010-2011.

    Rebecca Dent, Paul N. Mainwaring, Tira J. Tan +4

    Maqola20153 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434444

19. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess +10

    Maqola20233 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434446

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434427

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434435

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434440

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.434445